Drug name - Xyzal Allergy 24hr

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8633194 CHATTEM SANOFI Pharmaceutical composition of piperazine derivatives Oct, 2027

(5 years from now)

More Information on Dosage
Strength Dosage Availability
2.5MG/5ML SOLUTION;ORAL Over the counter

availability in other generic markets.

Click on the highlighted region to filter.